Quantification of total (G), stubby (H), mushroom (I), and thin (J) spine density in DG from control and susceptible mice treatment with ACSF or
ARL67156 (
n = 11, 13, 10 segments from 2, 4, 2 mice, respectively; for total density: Treatment
F
2,31 = 4.474,
P = 0.0196; CSDS – ASCF versus Ctrl – ACSF,
P = 0.0366; CSDS –
ARL67156 versus CSDS – ACSF,
P = 0.0086; stubby density: Treatment
F
2,31 = 3.327,
P = 0.0491; CSDS – ASCF versus Ctrl – ACSF,
P = 0.1026; CSDS –
ARL67156 versus CSDS – ACSF,
P = 0.0179; mushroom density: Treatment
F
2,31 = 1.986,
P = 0.1543; thin density:
F
2,31 = 1.475,
P = 0.2445, one‐way ANOVA with Fisher's LSD test).